SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001319244-24-000024
Filing Date
2024-02-08
Accepted
2024-02-08 16:36:20
Documents
1
Group Members
INTEGRATED CORE STRATEGIES (US) LLCISRAEL A. ENGLANDERMILLENNIUM GROUP MANAGEMENT LLCMILLENNIUM MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 SYRE_SC13GA2.htm SC 13G/A 93922
  Complete submission text file 0001319244-24-000024.txt   95940
Mailing Address C/O MILLENNIUM MANAGEMENT LLC 399 PARK AVENUE NEW YORK NY 10022
Business Address C/O MILLENNIUM MANAGEMENT LLC 399 PARK AVENUE NEW YORK NY 10022 (212) 841-4100
INTEGRATED CORE STRATEGIES (US) LLC (Filed by) CIK: 0001319244 (see all company filings)

IRS No.: 980330397 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Subject) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89456 | Film No.: 24609673
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)